The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Endoscopic monitoring of Crohn's disease treatment: A prospective, randomized clinical trial
Abstract
A randomized clinical trial was conducted to determine whether colonoscopy is useful in deciding how long to maintain steroid treatment in attacks of Crohn's disease involving the colon. One hundred forty-seven patients with acute attacks of colonic or ileocolonic Crohn's disease were treated by oral prednisolone, 1 mg.kg-1.day-1; 136 achieved clinical remission, but 96 of them still had active endoscopic lesions and were randomized either to immediate start of steroid tapering (group A; n = 46) or to continued prednisolone treatment at the same dosage for 5 more weeks before steroid tapering was begun (group B; n = 50). In the remaining 40 patients (already in endoscopic remission, group C), steroid tapering was begun immediately. After prednisolone discontinuation, patients were followed up for 18 months or until clinical relapse. Prolongation of prednisolone therapy significantly improved the endoscopic scores in group B (30% of endoscopic remission). The frequency of successful steroid weaning was almost identical in groups A and B (82% and 80%, respectively), as was the actuarially calculated relapse clinical rate after steroid withdrawal (P = 0.22). No factor predictive of clinical relapse could be found. The clinical course of patients in group C was similar to that of those in groups A and B. Overall, only 22% of the 147 patients were still in clinical remission and off steroids 18 months after prednisolone discontinuation, outlining the need for maintenance therapy. In conclusion, for patients who have achieved clinical remission, adjustment of steroid treatment duration on the basis of endoscopy results is of no benefit, and the endoscopic aspect has no prognostic value; thus, it appears unnecessary to repeat colonoscopy in such patients before steroid tapering is begun.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The GETAID group has repeatedly shown that endoscopic activity of Crohn's disease correlates either poorly or not at all with a clinical disease activity index 6, 7, 29 .”
From The Manitoba IBD Index: Evidence for a New and Simple Indicator of IBD Activity (2009) · cites this paper as [7]
Citations
Cites
Nonparametric Estimation from Incomplete Observations
Kaplan, E. L., & Meier, P. (1992) · Springer series in statistics · doi:10.1007/978-1-4612-4380-9_25 · Cited by 45,239
Regression Models and Life-Tables
Cox, D. R. (1972) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1972.tb00899.x · Cited by 39,793
Nonparametric Estimation from Incomplete Observations
Kaplan, E. L., & Meier, P. (1958) · Journal of the American Statistical Association · doi:10.1080/01621459.1958.10501452 · Cited by 39,158
Regression Models and Life-Tables
Cox, D. R. (1992) · Springer Series in Statistics · doi:10.1007/978-1-4612-4380-9_37 · Cited by 26,297
Nonparametric Statistics for the Behavioral Sciences.
Whitfield, J. W., & Siegel, S. (1957) · Journal of the Royal Statistical Society Series A (General) · doi:10.2307/2342828 · Cited by 8,017
Evaluation of survival data and two new rank order statistics arising in its consideration.
Mantel, N. (1966) · PubMed · Cited by 7,516
Cox, D. R., & Oakes, D. (2018) · Chapman & Hall/CRC eBooks · doi:10.1201/9781315137438 · Cited by 6,269
Breslow, N. E., Cox, D. R., & Oakes, D. (1985) · Biometrics · doi:10.2307/2530888 · Cited by 4,381
Non-Parametric Statistics for the Behavioral Sciences.
Stuart, A., & Siegel, S. (1957) · Economica · doi:10.2307/2551606 · Cited by 3,403
Predictability of the postoperative course of Crohn's disease
Rutgeerts, P., Geboes, K., Vantrappen, G., Beyls, J., Kerremans, R., & Hiele, M. I. (1990) · Gastroenterology · doi:10.1016/0016-5085(90)90613-6 · Cited by 1,814
Research works printed but not linked: 1
- Bernades, 1978, Proposition d'un système de critères pour le diagnostic des entérocolites inflammatoires (maladie de Crohn et rectocolite hémorragique). Une étude coopérative du GREC, Gastroenterol Clin Biol, 2, 1047
Cited by
Sorted by citations
Items 101–200 of 261
Pediatric Gastrointestinal Nuclear Medicine
Warrington, J. C., & Charron, M. (2007) · Seminars in Nuclear Medicine · doi:10.1053/j.semnuclmed.2007.02.005 · Cited by 36
Radiologic and Endoscopic Diagnosis of Crohn's Disease
Rubesin, S. E., Scotiniotis, I. A., Birnbaum, B. A., & Ginsberg, G. G. (2001) · Surgical Clinics of North America · doi:10.1016/s0039-6109(05)70273-5 · Cited by 36
Feuerstein, J. D., Rubin, D. T., Aberra, F. N., Yarur, A. J., & Malter, L. B. (2025) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2025.05.019 · Cited by 38
The Role of Mucosal Healing in the Treatment of Patients With Inflammatory Bowel Disease
Vaughn, B. P., Shah, S., & Cheifetz, A. S. (2014) · Current Treatment Options in Gastroenterology · doi:10.1007/s11938-013-0008-1 · Cited by 34
Recent Advances of Endoscopy in Inflammatory Bowel Diseases
Cheon, J. H., & Kim, W. H. (2007) · Gut and Liver · doi:10.5009/gnl.2007.1.2.118 · Cited by 34
Mucosal Healing in Ulcerative Colitis
Seidelin, J. B., Coskun, M., & Nielsen, O. H. (2012) · Advances in clinical chemistry · doi:10.1016/b978-0-12-405211-6.00004-8 · Cited by 33
Endoscopic evaluation of patients with inflammatory bowel disease
Simpson, P. A., & Papadakis, K. A. (2008) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20398 · Cited by 33
Franchimont, D. P., Louis, E., Dupont, P., VRINDTS‐GEVAERT, Y., Dewé, W., Chrousos, G. P., Geenen, V. G., & Belaiche, J. (1999) · Digestive Diseases and Sciences · doi:10.1023/a:1026644711530 · Cited by 33
Wong, E. C. L., Marshall, J. K., Reinisch, W., & Narula, N. (2020) · Inflammatory Bowel Diseases · doi:10.1093/ibd/izaa214 · Cited by 31
Targeting Mucosal Healing in Crohn's Disease.
Kakkar, A., Wasan, S. K., & Farraye, F. A. (2011) · Europe PMC (PubMed Central) · Cited by 30
Charron, M., Lorenzo, C. D., & Kocoshis, S. A. (2000) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(00)00803-0 · Cited by 30
Enteral Nutrition in Crohn’s Disease: An Underused Therapy
Kansal, S., Wagner, J., Kirkwood, C. D., & Catto‐Smith, A. G. (2013) · Gastroenterology Research and Practice · doi:10.1155/2013/482108 · Cited by 30
“Prolonged immune suppression with immunomodulators is also concerning owing to the risk of opportunistic infections besides problems with hematologic disorders [13].”
BackgroundNiv, Y., Gal, E., Gabovitz, V., Hershkovitz, M., Lichtenstein, L., & Avni, I. (2016) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0000000000000720 · Cited by 29
Association of Crohn's disease and Cogan's syndrome
Froehlich, F., Fried, M., Gonvers, J. J., Saraga, E. P., Thorens, J., & Pécoud, A. R. (1994) · Digestive Diseases and Sciences · doi:10.1007/bf02087569 · Cited by 29
Patients With Crohn's Disease Are Unaware of the Risks That Smoking Has on Their Disease
Ryan, W. R., Ley, C., Allan, R. N., & Keighley, M. R. B. (2003) · Journal of Gastrointestinal Surgery · doi:10.1016/s1091-255x(03)00066-0 · Cited by 29
Clinical trials in luminal Crohn's disease: A historical perspective
Hindryckx, P., Baert, F., Hart, A. L., Armuzzi, A., Panés, J., & Peyrin‐Biroulet, L. (2014) · Journal of Crohn s and Colitis · doi:10.1016/j.crohns.2014.04.007 · Cited by 28
Treat the Patient or Treat the Disease?
Hanauer, S. B., & Kirsner, J. B. (2012) · Digestive Diseases · doi:10.1159/000338139 · Cited by 26
Fahrni, A. (2003) · International Journal for Quality in Health Care · doi:10.1093/intqhc/15.1.15 · Cited by 26
Barnes, E. L., & Allegretti, J. R. (2015) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0000000000000441 · Cited by 25
Narula, N., Wong, E. C. L., Dulai, P. S., Marshall, J. K., Colombel, J., & Reinisch, W. (2020) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjaa189 · Cited by 25
Long-Term Outcome of Crohn's Disease Following Corticosteroid-Induced Remission
Papi, C., Festa, V., Leandro, G., Moretti, A., Tanga, M., Koch, M., & Capurso, L. (2007) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2007.01055.x · Cited by 25
Kjeldsen, J., Lauritsen, K., Schaffalitzky, O. B., & de Muckadell, O. B. S. (1997) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365529709011205 · Cited by 25
ULCERATIVE COLITIS AND CROHN’S DISEASE IN CHILDREN
Kirschner, B. S. (1995) · Gastroenterology Clinics of North America · doi:10.1016/s0889-8553(21)00250-8 · Cited by 25
Seidelin, J. B. (2015) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365521.2016.1101245 · Cited by 24
“at least in CD.[195,196] The potential beneficial effects”
BackgroundNutritional therapy for the treatment of pediatric Crohn’s disease
Otley, A. R., Russell, R. K., & Day, A. S. (2010) · Expert Review of Clinical Immunology · doi:10.1586/eci.10.37 · Cited by 24
Nishikawa, T., Nakamura, M., Yamamura, T., Maeda, K., Sawada, T., Mizutani, Y., Ishikawa, E., Ishikawa, T., Kakushima, N., Furukawa, K., et al. (2020) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.15366 · Cited by 23
Gelbmann, C. M. (2000) · Inflammatory Bowel Diseases · doi:10.1097/00054725-200005000-00009 · Cited by 23
Assessment of terminal ileal and colonic inflammation in Crohn's disease with 99mTc-WBC
Charron, M., del Rosario, J. F., & Kocoshis, S. A. (1999) · Acta Paediatrica · doi:10.1111/j.1651-2227.1999.tb01081.x · Cited by 23
Management of Crohn’s Disease and Complications in Patients With Ostomies
Wang, X., & Shen, B. (2018) · Inflammatory Bowel Diseases · doi:10.1093/ibd/izy025 · Cited by 21
Nutrition Issues in Pediatric Crohn's Disease
Wiskin, A. E., Wootton, S. A., & Beattie, R. M. (2007) · Nutrition in Clinical Practice · doi:10.1177/0115426507022002214 · Cited by 21
Miele, E., Pascarella, F., Quaglietta, L., Giannetti, E., Greco, L., Troncone, R., & Staiano, A. (2007) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2007.03291.x · Cited by 20
Seidelin, J. B., Larsen, S., Linnemann, D., Vainer, B., Coskun, M., Troelsen, J. T., & Nielsen, O. H. (2014) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00089.2014 · Cited by 20
The management of refractory Crohn's disease
Rizzello, F., Gionchetti, P., Venturi, A., Morselli, C., & Campieri, M. (2002) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.16.s4.6.x · Cited by 20
Narula, N., Wong, E. C. L., Dulai, P. S., Marshall, J. K., Colombel, J., & Reinisch, W. (2021) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjab045 · Cited by 19
Stanescu-Siegmund, N., Nimsch, Y., Wunderlich, A. P., Wagner, M., Meier, R., Juchems, M. S., Beer, M., & Schmidt, S. A. (2016) · Acta Radiologica · doi:10.1177/0284185116648503 · Cited by 19
Pediatric Inflammatory Bowel Disease Imaged with Tc-99m White Blood Cells
Charron, M. (2000) · Clinical Nuclear Medicine · doi:10.1097/00003072-200009000-00012 · Cited by 19
Medical management of chronic inflammatory bowel disease
MURCH, S. H., & Walker-Smith, J. A. (1994) · Baillière s Clinical Gastroenterology · doi:10.1016/s0950-3528(06)80023-0 · Cited by 19
Vadlamudi, N. B., Alkhouri, N., Mahajan, L. A., López, R., & Shen, B. (2010) · Digestive Diseases and Sciences · doi:10.1007/s10620-010-1332-0 · Cited by 18
“After permanent or diverting ileostomy, disease recurrence occurs most commonly at the neoterminal ileum [3, 4], usually within weeks to months after restoration of bowel continuity [5].”
BackgroundFerrante, M., Κarmiris, K., Newnham, E., Siffledeen, J. S., Zelinková, Z., Assche, G. V., Lakatos, P. L., Panés, J., Sturm, A., Travis, S. P. L., et al. (2011) · Journal of Crohn s and Colitis · doi:10.1016/j.crohns.2011.09.009 · Cited by 18
Review article: biological drugs in Crohn's disease
Kamm, M. A. (2006) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2006.03066.x · Cited by 18
“In a French study utilizing 1 mg/kg/day, a remission rate of 92% was achieved at 7 weeks.(3) There is general agreement that steroids should not be used long term to maintain remission, because of their adverse effects.”
BackgroundMucosal healing in Crohnʼs disease and ulcerative colitis: what does it tell us?
Flynn, A. D., & Kane, S. V. (2011) · Current Opinion in Gastroenterology · doi:10.1097/mog.0b013e3283455c8f · Cited by 17
Ashton, J. J., Coelho, T. A. F., Ennis, S., Vadgama, B., Batra, A., Afzal, N. A., & Beattie, R. M. (2015) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/mpg.0000000000001032 · Cited by 17
Endogenous Regulation of Inflammatory Pain by T-cell-derived Opioids
Basso, L., Boué, J., Bourreille, A., & Dietrich, G. (2014) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000000073 · Cited by 17
“complain of abdominal pain still have significant endoscopic lesions, which occasionally include deep ulceration.(79) The absence of abdominal pain, combined with a disease monitoring based on”
BackgroundTop-down approach to biological therapy of Crohn’s disease
Hirschmann, S., & Neurath, M. F. (2017) · Expert Opinion on Biological Therapy · doi:10.1080/14712598.2017.1287170 · Cited by 17
“These results suit to the findings of earlier reports, that nonbiologic treatments like corticosteroids or immunosuppressants are not as effective as anti-TNF therapies, regarding mucosal healing [14,15].”
ResultGelbmann, C. M., Rogler, G., Gierend, M., Groß, V., Schölmerich, J., & Andus, T. (2001) · European Journal of Gastroenterology & Hepatology · doi:10.1097/00042737-200112000-00006 · Cited by 17
Mossop, H., Davies, P. S. W., & Murphy, M. (2008) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/mpg.0b013e318156a834 · Cited by 17
Higaki, S., Nakano, K., Onaka, S., Amano, A., Tanioka, Y., Harada, K., Hashimoto, S., Sakaida, I., & Okita, K. (2006) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2006.04319.x · Cited by 16
B. SIMONIS, M. H. (1998) · Scandinavian Journal of Gastroenterology · doi:10.1080/00365529850170874 · Cited by 15
Mucosal healing as a treatment for IBD?
Papi, C., & Aratari, A. (2014) · Expert Review of Gastroenterology & Hepatology · doi:10.1586/17474124.2014.902302 · Cited by 15
“Conversely, observational studies failed to report a clear impact of healing of mucosal lesions on relapse rate in CD patients with corticosteroidinduced remission [2].”
BackgroundAssessing disease activity and disease activity indices for inflammatory bowel disease
Li, F. X., & Sutherland, L. R. (2002) · Current Gastroenterology Reports · doi:10.1007/s11894-002-0025-z · Cited by 14
Beattie, R. M. (2005) · Journal of Parenteral and Enteral Nutrition · doi:10.1177/01486071050290s4s151 · Cited by 14
Role of Endoscopy in Inflammatory Bowel Disease
Seidman, E. G. (2001) · Gastrointestinal Endoscopy Clinics of North America · doi:10.1016/s1052-5157(18)30041-2 · Cited by 14
Assessment of presence and grade of activity in ileal Crohn’s disease
Yüksel, E. S., İpek, S., Topal, F., Koç, G., Akpınar, Z., Slaughter, J. C., Oyar, O., & Ünsal, B. (2014) · The Turkish Journal of Gastroenterology · doi:10.5152/tjg.2014.3862 · Cited by 13
Bozkurt, T., Rommel, T., Stabenow-Lohbauer, U., Langer, M., Schmiegelow, P., & Lux, G. (1996) · European Journal of Ultrasound · doi:10.1016/0929-8266(95)00169-7 · Cited by 13
The Effect of Mesalamine and Nicotine in the Treatment of Inflammatory Bowel Disease
Bonapace, C. R., & Mays, D. A. (1997) · Annals of Pharmacotherapy · doi:10.1177/106002809703100719 · Cited by 13
Infliximab use in Crohn’s disease
Bewtra, M., & Lichtenstein, G. R. (2005) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.5.4.589 · Cited by 13
“(2005) 5(4) efficacy, however, have not shown a relationship between symptomatic relief and endoscopic evidence of intestinal mucosal healing, even with long periods of corticosteroid use [3-5].”
BackgroundPicco, M. F., Krishna, M., Cangemi, J. R., & Shelton, D. (2006) · Inflammatory Bowel Diseases · doi:10.1097/01.ibd.0000225345.29603.7d · Cited by 13
Chronic active disease and maintaining remission in Crohn's disease
Kamm, M. A. (2004) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2004.02052.x · Cited by 12
11. Appropriateness of Colonoscopy: Inflammatory Bowel Disease 1
Froehlich, Larequi-Lauber, Gonvers, Dubois, Burnand, & Vader (1999) · Endoscopy · doi:10.1055/s-1999-126 · Cited by 12
Steroid Use in Crohn’s Disease
Vavricka, S. R., Schoepfer, A. M., Scharl, M. M., & Rogler, G. (2014) · Drugs · doi:10.1007/s40265-014-0183-y · Cited by 11
“Two studies showed a 29% rate of endoscopic remission with corticosteroid therapy (38, 39).”
BackgroundKang, Y., Park, S., Kim, S., Kim, S. Y., & Koh, H. (2019) · Pediatric Gastroenterology Hepatology & Nutrition · doi:10.5223/pghn.2019.22.1.72 · Cited by 11
“histologic inflammatory lesions despite their beneficial effect on clinical response [18,19].”
Therapy of Crohn??s Disease in Childhood
Beattie, R. M. (2000) · Pediatric Drugs · doi:10.2165/00128072-200002030-00004 · Cited by 11
Medical Therapy of Steroid-Resistant Crohn's Disease
Sands, B. E. (2000) · Canadian Journal of Gastroenterology · doi:10.1155/2000/805015 · Cited by 11
Retrospective Analysis of Alternate-Day Predn'isone Maintenance Therapy for Crohn's Disease
del Rosario, J. F., Orenstein, S. R., Neigut, D. A., Giarrusso, V. S., Wolfson, N., & Kocoshis, S. A. (1998) · Clinical Pediatrics · doi:10.1177/000992289803700703 · Cited by 11
Kotze, P. G., Abou-Rejaile, V., Uiema, L. A., Olandoski, M., Sartor, M. C., Miranda, E. F., Kotze, L. M. D. S., & Saad-Hossne, R. (2014) · Arquivos de Gastroenterologia · doi:10.1590/s0004-28032014000100009 · Cited by 10
Top-Down Therapy: Is the Evidence Strong Enough?
Domènech, E., Mañosa, M., & Cabré, E. (2009) · Digestive Diseases · doi:10.1159/000228565 · Cited by 9
Indium scanning in assessment of acute Crohn's disease
Heresbach, D., Bretagne, J., Raoul, J., Moisan, A., Siproudhis, L., Devillers, A., & Gosselin, M. (1993) · Digestive Diseases and Sciences · doi:10.1007/bf01303166 · Cited by 9
“Moreover, a more recent study has demonstrated that the prolongation of prednisolone therapy for five additional weeks in such patients in clinical remission but with active endoscopic lesions had no benefit when considering the outcome of Crohn's disease (frequency of successful steroid weaning and the cumulative rat…”
de Britto, M. A. P., Soletti, R. C., Schanaider, A., Madi, K., de Souza, H. S. P., & Machado, J. C. (2013) · International Journal of Colorectal Disease · doi:10.1007/s00384-013-1755-0 · Cited by 8
Medical therapy for Crohn’s disease
Hanauer, S. B., & Dassopoulos, T. (2007) · Springer eBooks · doi:10.1007/0-387-25808-6_33 · Cited by 8
Kucharski, M., Karczewski, J., Mańkowska‐Wierzbicka, D., Karmelita‐Katulska, K., Kaczmarek, E., Iwanik, K., Rzymski, P., Grzymislawski, M. B., Linke, K., & Dobrowolska, A. (2016) · Gastroenterology Research and Practice · doi:10.1155/2016/7896478 · Cited by 8
Lopes, S., Andrade, P., Rodrigues‐Pinto, E., Afonso, J., Macedo, G., & Magro, F. (2017) · World Journal of Gastroenterology · doi:10.3748/wjg.v23.i35.6482 · Cited by 8
Medical therapy for Crohn’s disease
Hanauer, S. B. (1999) · Current Opinion in Gastroenterology · doi:10.1097/00001574-199907000-00006 · Cited by 8
Systematic review on drug and diet-induced endoscopic remission in Crohnʼs disease
Pimentel‐Nunes, P., Dinis-Ribeiro, M. J., & Magro, F. (2009) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0b013e3283196b03 · Cited by 7
Sandborn, W. J. (2000) · Current Opinion in Gastroenterology · doi:10.1097/00001574-200007000-00005 · Cited by 7
Schölmerich, J. (2006) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2006.03057.x · Cited by 7
Liu, J. K., & Lichtenstein, G. R. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4377-1529-3.00021-x · Cited by 6
Are endoscopic grading and scoring systems in inflammatory bowel disease the same?
Shen, J., Hua, R. Z., Lu, T. J., Xiang, C., & Dong, X. S. (2008) · Saudi Medical Journal · doi:10.15537/1658-3175.4498 · Cited by 6
Technetium leukocyte imaging in inflammatory bowel disease
Charron, M. (1999) · Current Gastroenterology Reports · doi:10.1007/s11894-999-0042-2 · Cited by 6
Gelbmann, C. M. (2007) · Inflammatory Bowel Diseases · doi:10.1002/ibd.3780060210 · Cited by 6
Soleimani, S., Moradkhani, A., Eftekhari, M., Rahmanian, F., & Moosavy, S. H. (2020) · Middle East Journal of Digestive Diseases · doi:10.34172/mejdd.2020.178 · Cited by 5
Budesonide in inflammatory bowel disease
Lamers, C. B. H. W., Wagtmans, M. J., VANDERSLUYSVEER, A., VANHOGEZAND, R., & Griffioen, G. G. (1996) · The Netherlands Journal of Medicine · doi:10.1016/0300-2977(95)00090-9 · Cited by 5
Errores frecuentes en el manejo del paciente grave con enfermedad inflamatoria intestinal
Gisbert, J. P., & Gomollón, F. (2007) · Gastroenterología y Hepatología · doi:10.1157/13101982 · Cited by 5
Endoscopy in Inflammatory Bowel Diseases
D’Haens, G., & Rutgeerts, P. J. (2003) · doi:10.1002/9780470986943.ch48 · Cited by 5
Decisões clínicas na doença de Crohn
Magro, F., Correia, L., Lago, P. M., Macedo, G., Peixe, P., Portela, F., Dias, J. A., Barros, L. M., Belo, T., Caldeira, P. M., et al. (2012) · Repositório Comum (Repositório Científico de Acesso Aberto de Portugal) · Cited by 4
Mucosal healing effect of nilotinib in indomethacin-induced enterocolitis: A rat model
Hakim, G. D. (2015) · World Journal of Gastroenterology · doi:10.3748/wjg.v21.i44.12576 · Cited by 4
Standards for Trials of Therapy in Inflammatory Bowel Disease
Sutherland, L. R., Hanauer, S., & Schölmerich, J. (1997) · Inflammatory Bowel Diseases · doi:10.1002/ibd.3780030406 · Cited by 4
Manes, G., Imbesi, V., Ardizzone, S., Cassinotti, A., Bosani, M., Massari, A., & Porro, G. B. (2008) · Digestive and Liver Disease · doi:10.1016/j.dld.2008.10.006 · Cited by 4
Charron, M. (2003) · Clinical Nuclear Medicine · doi:10.1097/01.rlu.0000093285.10199.78 · Cited by 4
Endoscopy as a Prognostic Marker in Inflammatory Bowel Disease
Camus, M., Pariente, B., Dray, X., Allez, M., & Marteau, P. R. (2013) · Digestive Diseases · doi:10.1159/000354691 · Cited by 4
Griffiths, A. M. (1999) · KARGER eBooks · doi:10.1159/000061784 · Cited by 4
Lymphocyte apheresis in Crohn's disease
CHADWICK, V. S. (1994) · Gastroenterology · doi:10.1016/0016-5085(94)90186-4 · Cited by 4
Laharie, D., Vuitton, L., Bourreille, A., Bouhnik, Y., Colombel, J., Louis, E., Fuméry, M., Mailhat, C., Mary, J., & Peyrin‐Biroulet, L. (2024) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjae122 · Cited by 3
Self-citationColonoscopic Findings in Crohn’s Disease ‐ Reproducible, But of Questionable Benefit
Holloway, H., & Fielding, J. (1996) · Canadian Journal of Gastroenterology and Hepatology · doi:10.1155/1996/353967 · Cited by 3
Clinical perspectives in inflammatory bowel disease
Selby, W. S. (1996) · Australian and New Zealand Journal of Medicine · doi:10.1111/j.1445-5994.1996.tb02901.x · Cited by 3
Griffiths, A. M. (2001) · Inflammatory Bowel Diseases · doi:10.1097/00054725-200111000-00012 · Cited by 3
Franchimont, D. P., Louis, E. J., Dupont, P., Geenen, V. G., & Bélaïche, J. (1998) · Gastroenterology · doi:10.1016/s0016-5085(98)83985-1 · Cited by 3
Analysis of biological variables in Crohn's disease.
Brignola, C., Belloli, C., SIMONE, G. D., Campieri, M., Gionchetti, P., & Belluzzi, A. (1996) · Gut · doi:10.1136/gut.38.6.938 · Cited by 3
de Carvalho, M. F., Carlos, A. D. S., Kum, A. S. T., Bestetti, A. M., Gomes, I. L. C., de Oliveira, L. B., Baroni, L., Bernardo, W. M., & de Moura, E. G. H. (2024) · Inflammatory Bowel Diseases · doi:10.1093/ibd/izae144 · Cited by 2
Healing the mucosa in Crohn’s disease: does it matter?
Ling, K. L., Chuah, S. W., & Kong, S. (2013) · Singapore Medical Journal · doi:10.11622/smedj.2013070 · Cited by 2
The Future of Molecular Approaches to Inflammatory Bowel Disease
Kabakchiev, B., Halder, S. L. S., & Silverberg, M. S. (2009) · Molecular Diagnosis & Therapy · doi:10.1007/bf03256328 · Cited by 2
Metadata
- Authors
- Landi, B., Anh, T. N., Cortot, A., Soule, J. C., Rene, E., Gendre, J. P., Bories, P., See, A., Metman, E. H., Florent, C., Lerebours, E., Mary, J. Y., & Modigliani, R.
- Affiliations
- Inserm (FR)
- Venue
- Gastroenterology
- Publisher
- Elsevier BV
- Published
- 1992-05
- Volume
- 102
- Issue
- 5
- Pages
- 1647-1653
- ISSN
- 0016-5085 (ISSN-L)
- OpenAlex
- W1876519312
- Cited by
- 261
- References
- 26
- Citations by year
- 2025: 1 · 2024: 3 · 2023: 2 · 2022: 3 · 2021: 4 · 2020: 7 · 2019: 3 · 2018: 5 · 2017: 5 · 2016: 4 · 2015: 13 · 2014: 13 · 2013: 16 · 2012: 10
- FWCI
- 3.50
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Gastroenterology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Gastroenterology › Inflammatory Bowel Disease
- Health Sciences › Medicine › Ophthalmology › Ocular Diseases and Behçet’s Syndrome
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Pregnancy and Medication Impact
- Keywords
- Crohn's disease, colonoscopy, endoscopic surveillance, prednisolone, corticosteroid tapering, corticosteroid withdrawal, endoscopic remission, clinical relapse, maintenance therapy, colonic Crohn's disease, ileocolonic Crohn's disease
- MeSH terms
- Adult, Colonoscopy, Crohn Disease, Female, Follow-Up Studies, Humans, Male, Prednisolone, Prospective Studies
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review